Bellerophon Therapeutics Inc
(BLPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | -46,227 | N/A | N/A |
| Depreciation Amortization | 85 | N/A | N/A |
| Other Working Capital | 5,314 | N/A | N/A |
| Other Operating Activity | 4,604 | 0 | 0 |
| Operating Cash Flow | $-36,224 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -3,478 | N/A | N/A |
| Investing Cash Flow | $-3,478 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 39,702 | 0 | 0 |
| Financing Cash Flow | $39,702 | $N/A | $N/A |
| Net Cash Flow | $N/A | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -36,224 | N/A | N/A |
| Capital Expenditure | -3,478 | N/A | N/A |
| Free Cash Flow | -39,702 | 0 | 0 |